Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers

Long non‐coding NR2F1‐AS1 is associated with tumor recurrence in estrogen receptor‐positive breast cancers

The tenacity of late recurrence of estrogen receptor (ER)‐positive breast cancer remains a major clinical issue to overcome. The administration of endocrine therapies within the first 5 years substantially minimizes the risk of relapse; however, some tumors reappear 10–20 years after the initial dia...

Full description

Bibliographic Details
Main Authors: Anna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, Ai Hironaka‐Mitsuhashi, Makiko Ono, Hitoshi Tsuda, Akihiko Shimomura, Kenji Tamura, Fumitaka Takeshita, Takahiro Ochiya, Yusuke Yamamoto
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Molecular Oncology
Subjects:
dormancy
ER‐positive breast cancer
late recurrence
lncRNA
PR/ER transcriptional complex
Online Access:https://doi.org/10.1002/1878-0261.12704

Internet

https://doi.org/10.1002/1878-0261.12704

Similar Items